First successful procedures performed with Implanet Jazz Lock implant

2552

jazz-lock-receives-fda-510k-clearance-and-ce-mark

Implanet has announced successful results for the first surgical procedures using the Jazz Lock.

Having obtained CE marking and 510K clearance, Jazz Lock has been used in select hospitals in France, Italy and the USA. According to a press release, following the initially positive results from the first 25 cases, Implanet intends to carry out a wide-scale international launch of Jazz Lock by the end of the year.

The first component of a range of band products designed for degenerative spine disorder surgery, Jazz Lock is intended to simplify the surgical procedure by replacing the locking screw and connecting rod with a locking system.

Vincent Cunin, deputy chief of service in the Spine Surgery department at Hospices Civils de Lyon (Lyon, France) says, “As a spinal surgeon, I have been using band implants for the last four years to correct spinal deformities, with excellent postoperative clinical results…This new implant’s ease of use during the first surgical procedures in Lyon, as well as the very encouraging initial postoperative clinical results, validate our choice. We will now follow these patients to confirm the long term results.”